BD (Becton, Dickinson and Company) (NYSE: BDX) has voluntarily executed a product recall of certain lots of BD Q-Syte™ Luer Access Devices and BD Nexiva™ Closed IV Catheter Systems. Use of the ...

Becton, Dickinson & Co. voluntarily expanded the Class I recall of millions of its Q-Syte Luer access devices to include its Nexiva intravenous catheter systems. The recall, initiated last October, ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD is recommending customers destroy certain unused ...

The Association for Aseptic Practice (ASAP) announced today that it endorses BD Nexiva TM Closed IV Catheter System as a best practice medical device that has been designed to address specific ...

CHICAGO, Feb 8 (Reuters) - Becton Dickinson & Co said it has voluntarily recalled millions of its intravenous infusion therapy devices distributed worldwide because the products could cause a ...

BETHLEHEM, PA--(Marketwired - Jun 6, 2016) - B. Braun Medical Inc. announced today that it and B. Braun Melsungen AG and B. Braun Medical Industries Sdn. Bhd. (B. Braun) have filed a lawsuit against ...

Now equipped with U.S. Food and Drug Administration clearance to market its first product, University of Michigan spinoff Tangent Medical Technologies has raised $8.6 million, presumably to take its ...

- There is robust evidence that the BD vascular care solution and skin antiseptic for peripheral intravenous catheters used in the CLEAN3 randomized clinical trial can help improve patient outcomes - ...